Hydroxyapatite-containing product in parenteral dose form

Product containing durapatite in parenteral dose form (medicinal product form)

medicinal product form

£1.00

Supplier: international · SCTID 783909006

Also known as (2)

Durapatite-containing product in parenteral dose form
Hydroxyapatite-containing product in parenteral dose form

Found in

Hydroxyapatite-containing product Product manufactured as parenteral dose form

Related products

Abaloparatide-containing product in parenteral dose form

£1.00

Abatacept-containing product in parenteral dose form

£1.00

Abciximab-containing product in parenteral dose form

£1.00

AbobotulinumtoxinA-containing product in parenteral dose form

£1.00

Acetazolamide-containing product in parenteral dose form

£1.00

Acetylcholine-containing product in parenteral dose form

£1.00

Aciclovir-containing product in parenteral dose form

£1.00

Aclarubicin-containing product in parenteral dose form

£1.00

Adalimumab-containing product in parenteral dose form

£1.00

Adenosine-containing product in parenteral dose form

£1.00

Adrenaline-containing product in parenteral dose form

£1.00

Aducanumab-containing product in parenteral dose form

£1.00

Afamelanotide-containing product in parenteral dose form

£1.00

Aflibercept-containing product in parenteral dose form

£1.00

Agalsidase alfa-containing product in parenteral dose form

£1.00

Agalsidase beta-containing product in parenteral dose form

£1.00

Albiglutide-containing product in parenteral dose form

£1.00

Albumin human-containing product in parenteral dose form

£1.00

Aldesleukin-containing product in parenteral dose form

£1.00

Alemtuzumab-containing product in parenteral dose form

£1.00

Alfacalcidol-containing product in parenteral dose form

£1.00

Alfentanil-containing product in parenteral dose form

£1.00

Alglucerase-containing product in parenteral dose form

£1.00

Alglucosidase alfa-containing product in parenteral dose form

£1.00

Total£0.00